Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Immune-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer. | J Oncol | 2021 | 34925511 | PubTator, text mining | PubMed |
| Malignant pleural mesothelioma: an update. | J Bras Pneumol | 2021 | 34909922 | PubTator, text mining | PubMed |
| Profile of Basal Cell Carcinoma Mutations and Copy Number Alterations - Focus on Gene-Associated Noncoding Variants. | Front Oncol | 2021 | 34900699 | PubTator, text mining | PubMed |
| Biological Adaptations of Tumor Cells to Radiation Therapy. | Front Oncol | 2021 | 34900673 | PubTator, text mining | PubMed |
| Hypoxia-induced Fascin-1 upregulation is regulated by Akt/Rac1 axis and enhances malignant properties of liver cancer cells via mediating actin cytoskeleton rearrangement and Hippo/YAP activation. | Cell Death Discov | 2021 | 34897283 | PubTator, text mining | PubMed |
| Retraction Note: Alginate oligosaccharide attenuates α2,6- sialylation modification to inhibit prostate cancer cell growth via the Hippo/YAP pathway. | Cell Death Dis | 2021 | 34887393 | PubTator, text mining | PubMed |
| Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers. | Cancers (Basel) | 2021 | 34885067 | PubTator, text mining | PubMed |
| Long Non-Coding RNA (lncRNA) in Oral Squamous Cell Carcinoma: Biological Function and Clinical Application. | Cancers (Basel) | 2021 | 34885054 | PubTator, text mining | PubMed |
| From Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Response to Cancer Onset via Molecular Mimicry and Cross-Reactivity. | Glob Med Genet | 2021 | 34877576 | PubTator, text mining | PubMed |
| Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges. | Front Cell Dev Biol | 2021 | 34869376 | PubTator, text mining | PubMed |
| miR-92a-3p Promoted EMT via Targeting LATS1 in Cervical Cancer Stem Cells. | Front Cell Dev Biol | 2021 | 34869346 | PubTator, text mining | PubMed |
| LIMD2 is a Prognostic and Predictive Marker in Patients With Esophageal Cancer Based on a ceRNA Network Analysis. | Front Genet | 2021 | 34868263 | PubTator, text mining | PubMed |
| HP1a-mediated heterochromatin formation inhibits high dietary sugar-induced tumor progression. | Cell Death Dis | 2021 | 34866135 | PubTator, text mining | PubMed |
| Hippo signaling suppresses tumor cell metastasis via a Yki-Src42A positive feedback loop. | Cell Death Dis | 2021 | 34862372 | PubTator, text mining | PubMed |
| Predictive modeling of gene expression regulation. | BMC Bioinformatics | 2021 | 34837938 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Value of Three microRNAs in Environmental Asbestiform Fibers-Associated Malignant Mesothelioma. | J Pers Med | 2021 | 34834557 | PubTator, text mining | PubMed |
| Mechanosensing and the Hippo Pathway in Microglia: A Potential Link to Alzheimer's Disease Pathogenesis? | Cells | 2021 | 34831369 | PubTator, text mining | PubMed |
| Evaluation of the Effectiveness of Herbal Components Based on Their Regulatory Signature on Carcinogenic Cancer Cells. | Cells | 2021 | 34831362 | PubTator, text mining | PubMed |
| Reciprocal Regulation of Hippo and WBP2 Signalling-Implications in Cancer Therapy. | Cells | 2021 | 34831354 | PubTator, text mining | PubMed |
| Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer's Disease. | Cells | 2021 | 34831245 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=51